Molecular basis of pharmacological therapy in Cushing’s disease

Endocrine ◽  
2013 ◽  
Vol 46 (2) ◽  
pp. 181-198 ◽  
Author(s):  
Diego Ferone ◽  
Claudia Pivonello ◽  
Giovanni Vitale ◽  
Maria Chiara Zatelli ◽  
Annamaria Colao ◽  
...  
2021 ◽  
Vol 4 (1) ◽  
Author(s):  
Keijun Kakihara ◽  
Kengo Asamizu ◽  
Kei Moritsugu ◽  
Masahide Kubo ◽  
Tetsuya Kitaguchi ◽  
...  

AbstractUbiquitin-specific protease 8 (USP8) is a deubiquitinating enzyme involved in multiple membrane trafficking pathways. The enzyme activity is inhibited by binding to 14-3-3 proteins. Mutations in the 14-3-3-binding motif in USP8 are related to Cushing’s disease. However, the molecular basis of USP8 activity regulation remains unclear. This study identified amino acids 645–684 of USP8 as an autoinhibitory region, which might interact with the catalytic USP domain, as per the results of pull-down and single-molecule FRET assays performed in this study. In silico modelling indicated that the region forms a WW-like domain structure, plugs the catalytic cleft, and narrows the entrance to the ubiquitin-binding pocket. Furthermore, 14-3-3 inhibited USP8 activity partly by enhancing the interaction between the WW-like and USP domains. These findings provide the molecular basis of USP8 autoinhibition via the WW-like domain. Moreover, they suggest that the release of autoinhibition may underlie Cushing’s disease due to USP8 mutations.


2018 ◽  
Vol 24 ◽  
pp. 185-186
Author(s):  
Sydney Blount ◽  
Marie Caldwell

2005 ◽  
Vol 11 ◽  
pp. 54-55
Author(s):  
Daniel K. Short ◽  
William F. Young

2013 ◽  
Vol 121 (10) ◽  
Author(s):  
M Riebold ◽  
M Theodoropoulou ◽  
C Kozany ◽  
F Hausch ◽  
GK Stalla ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document